Follow-The-Filings

Security · featured owners

IMVT Immunovant Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 1.1%
  • $233M
  • 1 add 1 reduce

IMVT (Immunovant Inc.) is held in 3 featured 13F books as of 2026 Q2. Nathan Fischel - Dafna Capital Management is the largest tracked holder by portfolio weight (1.1%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel Reduce 1.1%
  2. Farallon Capital Management Add 1.0%
  3. David Einhorn 0.09%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Farallon Capital Management 2026 Q2 1.0% Add +275.5% 5,805,000 $224M History
Nathan Fischel - Dafna Capital Management 2026 Q2 1.1% Reduce −0.7% 149,524 $6M History
David Einhorn - DME Capital Management 2026 Q2 0.09% Hold 93,520 $4M History

SEC filings

Recent issuer filings from EDGAR · 6 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 5.07
8-K 2.02,9.01
10-Q
DEFA14A
8-K 2.02,9.01
10-K

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Sep 23, 2026
4 Period Aug 28, 2026
4 Period Aug 20, 2026
4 Period Jul 23, 2026 · 2 forms
4 Period Jul 24, 2026
4 Period Jul 8, 2026 · 3 forms
4 Period Jul 1, 2026
4 Period Jun 26, 2026 · 5 forms
4 Period Jun 18, 2026
4 Period Jun 15, 2026
4 Period May 28, 2026
4 Period May 20, 2026
4 Period May 20, 2026
4 Period May 1, 2026
4 Period Apr 23, 2026 · 2 forms
4 Period Apr 8, 2026 · 2 forms

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Net income -$210.96M -$259.34M -$413.84M -$505.61M

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $404.33M $665.77M $767.66M $948.82M
Total non-current assets * $1.5M $0.595M $8.56M $8.2M
Total assets $405.84M $666.36M $776.22M $957.01M
Total current liabilities $43.3M $48.61M $68.78M $104.42M
Total non-current liabilities * $47,000 $0.00 $0.00 $0.00
Total equity $362.49M $617.76M $707.45M $852.59M

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations -$188.19M -$214.23M -$375.87M -$407.31M
Cash from investing -$197,000 -$360,000 -$759,000 -$8,000
Cash from financing $70.88M $472.43M $454.49M $595.76M
Net change in cash -$117.28M $258.83M $78.61M $188.14M

Ownership over time

filing count by report period · click a bar for that quarter’s holders